Patent details

Basic Information

Publication number:

EP2344142

PCT Application Number:

US2009056254

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097923254

PCT Publication Number:

WO2010030607

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS WITH REDOX-ACTIVE THERAPEUTICS

French Title of Invention:

TRAITEMENT DE TROUBLES GLOBAUX DU DÉVELOPPEMENT GRÂCE À DES AGENTS THÉRAPEUTIQUES À ACTIVITÉ OXYDO-RÉDUCTRICE

German Title of Invention:

BEHANDLUNG VON PERVASIVEN ENTWICKLUNGSSTÖRUNGEN MIT REDOX-AKTIVEN THERAPEUTIKA

SPC Number:

Dates

Filing date:

08/09/2009

Grant date:

26/06/2024

EP Publication Date:

20/07/2011

PCT Publication Date:

18/03/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/06/2024

EP B1 Publication Date:

26/06/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/09/2024

Expiration date:

08/09/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/06/2024

 

 

Name:

PTC Therapeutics, Inc.

Address:

500 Warren Corporate Center Drive, Warren, NJ 07059, United States (US)

Inventor

1

Name:

MILLER, Guy, M.

Address:

United States (US)

2

Name:

KHEIFETS, Viktoria

Address:

United States (US)

Priority

Priority Number:

191696 P

Priority Date:

10/09/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/05; A61K 31/122; A61P 25/00;

Publication

European Patent Bulletin

Issue number:

202426

Publication date:

26/06/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages